Tatsis Ourania's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Feb 14, 2022
- Accession no.
- 0001209191-22-009249
- Filed
- Feb 14, 2022
- Trade date
- Feb 10-11, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market sales total $68.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tatsis OuraniaCIK 0001789815 | Officer (EVP, Chief Reg. & Quality Off.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2022 | Common Stock | FTax withholdingDisposed | −1,230 | $237.74 | −$292,420.2 | 58,027 | Direct | |
| Feb 11, 2022 | Common Stock | SSaleDisposed | −100 | $233.92F2,F3 | −$23,392 | 57,927 | Direct | |
| Feb 11, 2022 | Common Stock | SSaleDisposed | −78 | $234.93F3,F4 | −$18,324.54 | 57,849 | Direct | |
| Feb 11, 2022 | Common Stock | SSaleDisposed | −70 | $235.87F3,F5 | −$16,510.9 | 57,779 | Direct | |
| Feb 11, 2022 | Common Stock | SSaleDisposed | −42 | $236.85F3,F6 | −$9,947.7 | 57,737 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Open market sales reported on this line occurred at a weighted average price of $233.92 (range $233.26 to $234.24).
Referenced by the price of 1 transaction in Table I.
- F3
Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 4 transactions in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $234.93 (range $234.28 to $235.25).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $235.87 (range $235.41 to $236.08).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $236.85 (range $236.84 to $236.87).
Referenced by the price of 1 transaction in Table I.